FREE SHIPPING for orders of AUD $50!

Modern life is full of sugar, and much of it is hidden. Modern food labels, if honest, should include the words “PLENTY OF ADDED SUGAR” in capital letters, because Obesity & Diabetes are becoming major pandemics.

But now there is a food, or rather an extract, which will allow you to lead a healthier life but with less worry about the hidden sugars in your daily life.

One dose of Shuga4 before or with each meal is composed of four well known potent herbs that are all heavily researched individually and found to have a positive effect on insulin sensitivity & response, Diabetes2, Diabetes2 Markers, Pre Diabetes, Obesity and Obesity Markers.

To our knowledge we are the first to combine these four very efficacious herbs in one easy to take extract.

Each 100 ml bottle contains cold extracted Goat’s Rue, Gymnema Silvestre, Nigella Sativa, & Fenugreek Seeds. 5 ml in water (approximately one teaspoon is taken before breakfast and one teaspoon is taken before (or with) lunch.

Many health professionals claim it is impossible to lose weight if you lose control of your insulin sensitivity.

Make the decision NOW! Start controlling your insulin sensitivity and your weight TODAY!

Two 100 ml bottles are AUD $49


$49.00 Add to cart

Four 100 ml bottles are AUD $88


$88.00 Add to cart

Twelve bottles are AUD $240


$240.00 Add to cart

Plus AUD $9 for post & packing. Post FREE for orders AUD $50 or over.

Order securely online or phone Kaye on 07 3823 3022 to order by phone.

And if you would like to read more about the ingredients then read these PubMed studies:

Biomed Res Int. 2014;2014:830285. doi: 10.1155/2014/830285. Epub 2014 Jan 6.

Phytochemical and pharmacological properties of Gymnema Silvestre: an important medicinal plant.

Tiwari P1, Mishra BN2, Sangwan NS1.

Author information

Abstract

Gymnema Silvestre (Asclepiadaceae), popularly known as “gurmar” for its distinct property as sugar destroyer, is a reputed herb in the Ayurvedic system of medicine. The phytoconstituents responsible for sweet suppression activity includes triterpene saponins known as gymnemic acids, gymnemasaponins, and a polypeptide, gurmarin. The herb exhibits a broad range of therapeutic effects as an effective natural remedy for diabetes, besides being used for arthritis, diuretic, anaemia, osteoporosis, hypercholesterolemia, cardiopathy, asthma, constipation, microbial infections, indigestion, and anti-inflammatory. G. Sylvester has good prospects in the treatment of diabetes as it shows positive effects on blood sugar homeostasis, controls sugar cravings, and promotes regeneration of pancreas. The herbal extract is used in dietary supplements since it reduces body weight, blood cholesterol, and triglyceride levels and holds great prospects in dietary as well as pharmacological applications. This review explores the transition of a traditional therapeutic to a modern contemporary medication with an overview of phytochemistry and pharmacological activities of the herb and its phytoconstituents.

PMID:

24511547

[PubMed – indexed for MEDLINE]

J Sci Food Agric. 2014 Mar 30;94(5):834-40. doi: 10.1002/jsfa.6458. Epub 2013 Nov 19.

A systematic review of Gymnema Silvestre in obesity and diabetes management.

Pothuraju R1, Sharma RK, Chagalamarri J, Jangra S, Kumar Kavadi P.

Author information

Abstract

The prevalence of obesity is associated with many health-related problems. Currently, more than 300 million people are considered to be obese. According to the World Health Organization (WHO), by 2030, 87 and 439 million people will be affected in India and the world, respectively. Today, herbal medicines are gaining interest in the treatment of obesity and diabetes, because of their minimal side effects. Gymnemic acid – an active component isolated from Gymnema Silvestre – has anti-obesity and antidiabetic properties, decreases body weight and also inhibits glucose absorption. Several components extracted from Gymnema prevent the accumulation of triglycerides in muscle and liver, and also decrease fatty acid accumulation in the circulation. In this paper, an attempt has been made to review the effects of various extracts from Gymnema Silvestre in the regulation of carbohydrate and lipid metabolism in both animal and clinical studies.

© 2013 Society of Chemical Industry.

KEYWORDS:

Gymnema Silvestre; diabetes; metabolism; obesity

PMID:

24166097

[PubMed – indexed for MEDLINE]

PLoS One. 2015 Feb 23;10(2):e0113486. doi: 10.1371/journal.pone.0113486. eCollection 2015.

Nigella Sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial.

Kaatabi H1, Bamosa AO1, Badar A1, Al-Elq A2, Abou-Hozaifa B1, Lebda F1, Al-Khadra A2, Al-Almaie S3.

Author information

Abstract

BACKGROUND AND OBJECTIVE:

Oxidative stress plays an important role in pathogenesis of diabetes mellitus and its complications. Our previous study has shown glucose lowering effect produced by 3 months supplementation of Nigella Sativa (NS) in combination with oral hypoglycemic drugs among type 2 diabetics. This study explored the long term glucose lowering effect (over one year) of NS in patients with type 2 diabetes mellitus on oral hypoglycemic drugs and to study its effect on redox status of such patients.

METHODS:

114 type 2 diabetic patients on standard oral hypoglycemic drugs were assigned into 2 groups by convenience. The control group (n = 57) received activated charcoal as placebo and NS group (n = 57) received 2g NS, daily, for one year in addition to their standard medications. Fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), C- peptide, total antioxidant capacity (TAC), superoxide dismutase (SOD), catalase (CAT), glutathione and thiobarbituric acid reactive substances (TBARS) at the baseline, and every 3 months thereafter were determined. Insulin resistance and β-cell activity were calculated using HOMA 2 calculator.

RESULTS:

Comparison between the two groups showed a significant drop in FBG (from 180 ± 5.75 to 180 ± 5.59 in control Vs from 195 ± 6.57 to 172 ± 5.83 in NS group), HbA1c (from 8.2 ± 0.12 to 8.5 ± 0.14 in control VS from 8.6 ± 0.13 to 8.2 ± 0.14 in NS group), and TBARS (from 48.3 ± 6.89 to 52.9 ± 5.82 in control VS from 54.1 ± 4.64 to 41.9 ± 3.16 in NS group), in addition to a significant elevation in TAC, SOD and glutathione in NS patients compared to controls. In NS group, insulin resistance was significantly lower, while β-cell activity was significantly higher than the baseline values during the whole treatment period.

CONCLUSION:

Long term supplementation with Nigella Sativa improves glucose homeostasis and enhances antioxidant defence system in type 2 diabetic patients treated with oral hypoglycemic drugs.

TRIAL REGISTRATION:

Clinical Trials Registry-India (CTRI) CTRI/2013/06/003781.

PMID:

25706772

[PubMed – in process]

PMCID:

PMC4338020

Antiinflamm Antiallergy Agents Med Chem. 2014 Mar;13(1):3-8.

Effect of dietary supplementation of black seed (N. Sativa L.) on lipid profile of patients suffering from diabetes.

Qidwai W, Ashfaq T1.

Author information

Abstract

Diabetes is a chronic metabolic problem closely related to cardiovascular disease leading to premature death. Dyslipidaemia is an important risk factor responsible for cardiovascular disease in patients with diabetes. This paper is based on review of articles published to observe the effect of N. Sativa (black seed) on lipid levels in patients suffering from Diabetes Mellitus. A search of indexed papers and clinical trials was done using MEDLINE and PubMed and Cochrane search engine. All studies assessing the effect of N. Sativa ingestion on lipid levels among diabetics (animal or human) were included. A total of 12 trials (6 human studies and 6 animal studies) fulfilling the inclusion criteria were reviewed. Majority of human and animal trials done among humans and animals with diabetes or metabolic syndrome demonstrated reduction in weight and improvement in serum lipid levels including decrease total lipids, triglycerides, LDL levels. However, increase in HDL level showed questionable results. N. Sativa L

PMID:

24484208

[PubMed – indexed for MEDLINE]

World J Gastroenterol. 2009 May 7;15(17):2170-1.

Emerging clinical and therapeutic applications of Nigella sativa in gastroenterology.

Kapoor S.

Abstract

Nigella Sativa (N. Sativa) decreases DNA damage and thereby prevents initiation of carcinogenesis in colonic tissue secondary to exposure to toxic agents such as azoxymethane. N. Sativa is of immense therapeutic benefit in diabetic individuals and those with glucose intolerance as it accentuates glucose-induced secretion of insulin besides having a negative impact on glucose absorption from the intestinal mucosa. N. Sativa administration protects hepatic tissue from deleterious effects of toxic metals such as lead, and attenuates hepatic lipid peroxidation following exposure to chemicals such as carbon tetrachloride.

PMID:

19418593

[PubMed – indexed for MEDLINE]

PMCID:

PMC2678591